Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

The drug is used to treat psychotic disorders such as schizophrenia

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 04:01 PM IST
article-image
Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet | Image: Ajanta Pharma (Representative)

Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.

The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.

The drug is used to treat psychotic disorders such as schizophrenia.

RECENT STORIES

'It's SEBI's Job To Regulate Futures And Options Market,' Says Finance Minister Nirmala Sitharaman

'It's SEBI's Job To Regulate Futures And Options Market,' Says Finance Minister Nirmala Sitharaman

Apple Slashes iPhone Prices in India Post-Budget 2024 Customs Duty Cut; Check Out the New Prices

Apple Slashes iPhone Prices in India  Post-Budget 2024 Customs Duty Cut; Check Out the New Prices

IndiGo Flags Higher Inflationary Environment, Escalation In Fuel, Airport Costs

IndiGo Flags Higher Inflationary Environment, Escalation In Fuel, Airport Costs

ITR Filing Countdown: Avoid Penalties and Late Fees – What You Need to Know Before the July 31...

ITR Filing Countdown: Avoid Penalties and Late Fees – What You Need to Know Before the July 31...

Gold Prices Rebound to ₹70,700 per 10 Grams Amid Global Market Strength

Gold Prices Rebound to ₹70,700 per 10 Grams Amid Global Market Strength